Oral fruquintinib combined with tegafur-gimeracil-oteracil potassium for advanced colorectal cancer to obtain longer progression-free survival: A case report

BACKGROUND: After the failure of second-line standard therapy, effective treatment options for metastatic colorectal cancer are limited, and the duration of remission cannot meet clinical needs. In addition, associated drug toxicity may lead to treatment interruption that may affect patient outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Fan-Jie, Wu, Shuang, Kong, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237021/
https://www.ncbi.nlm.nih.gov/pubmed/37275454
http://dx.doi.org/10.4251/wjgo.v15.i5.902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237021/
https://www.ncbi.nlm.nih.gov/pubmed/37275454
http://dx.doi.org/10.4251/wjgo.v15.i5.902

Ejemplares similares